Tackling Dry Socket Via Laser Therapy in Smokers

Tackling Dry Socket Via Dual Wavelength Laser Diode Therapy in Smokers: A Randomized Controlled Trial.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06481293

Enrollment

Registered

2024-07-01

Start date

2023-10-30

Completion date

2025-09-20

Last updated

2025-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Osteitis

Keywords

Diode laser, Dry socket

Brief summary

This study examines the efficiency of diode laser therapy to manage dry sockets after tooth extraction.

Detailed description

The study compares the efficiency of diode laser therapy and using only alveogyl to accelerate the healing of dry sockets after tooth extraction in smokers. Smoker patients with dry sockets were enrolled randomly into two different groups. Group 1 received dual wavelength laser diode therapy, three times per week. While group 2 received only a topical application of alveogl. The treatment lasted for two consecutive weeks. The treatment efficiency was evaluated by measuring the volume of the socket using the syringe method. The pain level was measured by the visual analog scale.

Interventions

DEVICEDiode laser therapy

Dual wavelength laser diode therapy device

COMBINATION_PRODUCTAlveogyl dressing

Alveogyl is a haemostatic-analgesic alveolar dressing

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

The study included two groups. One group receives dual wavelength laser diode therapy and the other group receives topical aveogyl dressing.

Eligibility

Sex/Gender

ALL

Age

25 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* Smokers patient

Exclusion criteria

* Females on contraceptives. * Diabetic patients * Hepatitis C virus patients * Patients on corticosteroids * Patients with renal diseases * Anemic patients

Design outcomes

Primary

Measure	Time frame	Description
Socket volume	2 weeks	measured through the volumetric measurement method using a syringe filled with saline

Secondary

Measure	Time frame	Description
Pain level	2 weeks	measured by the visual analogue scale(VAS). It include score from 0 to 10 in which 10 indicates the worst pain level and 0 indicates no pain

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026